SealCath

SealCath is a privately held, commercial-stage medical device company specializing in a novel double-balloon rectal catheter. Its flagship product, the Cephus Catheter, is FDA-cleared and addresses significant clinical pain points in radiology and gastroenterology by preventing leakage, reducing procedure time, and enhancing patient comfort. As a Service-Disabled Veteran Owned Small Business, the company also has a strategic focus on serving VA hospitals and military treatment facilities. SealCath is in the early revenue phase, leveraging direct sales and distributor partnerships to penetrate the hospital and outpatient clinic market.

Double-balloon mechanical sealing technology for leak-proof rectal access and insufflation during diagnostic imaging procedures.

The Cephus Catheter is first-to-market as the only FDA-cleared double-balloon rectal catheter. Its main competition is off-label use of standard Foley catheters (single balloon) and other rectal tips, which are less effective at preventing leakage. The competitive moat is the FDA clearance and patented dual-balloon design, but larger medical device companies could enter the space if the market proves attractive.